Performance status-3 - Symptomatic, 50 in bed Posts on Medivizor
Navigation Menu

Performance status-3 – Symptomatic, 50 in bed Posts on Medivizor

Treating chronic lymphocytic leukemia/small lymphocytic lymphoma with rituximab and high-dose methylprednisolone

Treating chronic lymphocytic leukemia/small lymphocytic lymphoma with rituximab and high-dose methylprednisolone

Posted by on Feb 6, 2022 in Leukemia | 0 comments

In a nutshell This study aimed to investigate using rituximab (Rituxan) and high-dose methylprednisolone (HDMP; Medrol) as a treatment for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).   This study concluded that this treatment is a good option for elderly and frail patients and can work as a bridge to...

Read More

Looking for patients with multiple myeloma to try a maintenance therapy combination after SCT

Looking for patients with multiple myeloma to try a maintenance therapy combination after SCT

Posted by on Sep 30, 2019 in Multiple Myeloma | 0 comments

In a nutshell This trial will compare the effectiveness of two maintenance therapies in patients with multiple myeloma (MM) after a stem cell transplant (SCT). The main outcome to be measured will be the average time from treatment until death due to any cause.  The details Maintenance therapy is commonly given after SCT to help delay...

Read More

Looking for patients with relapsed or unresponsive acute myeloid leukemia to test a new targeted therapy drug

Looking for patients with relapsed or unresponsive acute myeloid leukemia to test a new targeted therapy drug

Posted by on Jul 23, 2019 in Leukemia | 0 comments

In a nutshell This trial is examining the effectiveness of crenolanib after salvage chemotherapy for relapsed or unresponsive acute myeloid leukemia (AML) with FLT3 activating mutations. The main outcome would be survival without complications from leukemia 3 years after the treatment has finished. The details AML is a type of blood...

Read More

Evaluating a new CAR-T cell therapy for patients with relapsed or refractory multiple myeloma

Evaluating a new CAR-T cell therapy for patients with relapsed or refractory multiple myeloma

Posted by on Mar 10, 2019 in Multiple Myeloma | 0 comments

In a nutshell This study investigated the safety and effectiveness of a new chimeric antigen receptor (CAR) T cell therapy for relapsed or refractory (does not respond to treatment) multiple myeloma (MM). This study found that this cell therapy was effective, but it had significant side effects.   Some background MM is a type of cancer of the...

Read More

Should elderly patients with NSCLC be treated with less aggressive radiation therapy?

Should elderly patients with NSCLC be treated with less aggressive radiation therapy?

Posted by on Oct 26, 2017 in Lung cancer | 0 comments

In a nutshell This trial examined whether aggressive radiation would cause severe side effects in patients over 80 years old with early stage non-small-cell lung cancer (NSCLC). The authors concluded that SBRT is safe and tolerable for older patients. Some background Stereotactic body radiation therapy (SBRT) is a type of radiation that delivers...

Read More

Dealing with cancer pain: Low-dose morphine examined

Dealing with cancer pain: Low-dose morphine examined

Posted by on Feb 6, 2016 in Breast cancer | 0 comments

In a nutshell This study compared weak opioids and low-dose morphine in providing pain relief for moderate cancer pain. Researchers concluded that low-dose morphine is more suitable as pain management for moderate cancer pain than weaker pain relievers. Some background The guidelines for cancer pain relief developed by the World Health...

Read More

FDA approved drugs in the last 20 years for the treatment of Metastatic Breast Cancer

FDA approved drugs in the last 20 years for the treatment of Metastatic Breast Cancer

Posted by on Aug 31, 2014 in Breast cancer | 0 comments

The article reviews drugs that were approved by the US Food and Drug Administration (FDA) for the treatment of Metastatic Breast Cancer (MBC) in the last 20 years. The authors summarize the clinical studies which lead to FDA approval. ‘First-line therapy’ is the initial treatment used to reduce cancer burden. It is usually the standard...

Read More

Can chemotherapy make inoperable cancer operable?

Can chemotherapy make inoperable cancer operable?

Posted by on Sep 29, 2013 in Colorectal cancer | 0 comments

In a nutshell This study investigated the benefits of chemotherapy to treat inoperable (that cannot be removed through surgery) metastases from colorectal cancer (CRC). Some background When CRC is discovered early, the preferred method of treatment is surgery to remove the cancer along with some surrounding healthy tissue. Chemotherapy is often...

Read More

The benefit of adjuvant chemotherapy in the treatment of older patients with advanced colon cancer

Posted by on Aug 21, 2013 in Colorectal cancer | 0 comments

In a nutshell In this study, researchers examined how adjuvant chemotherapy benefits colon cancer patients over the age of 75. Some background Adjuvant chemotherapy (the addition of chemotherapy to another treatment, such as surgery) has been shown to benefit survival in multiple trials and is considered common practice for patients with advanced...

Read More

Comparison between two radiation therapy schedules

Comparison between two radiation therapy schedules

Posted by on Aug 9, 2013 in Lung cancer | 0 comments

In a nutshell This trial compared the survival of lung cancer patients, between patients receiving standard radiation therapy and those receiving radiation therapy given on alternative schedules (hyperfractionated or accelerated). Some background This research was prompted by recent findings that suggest a benefit with hyperfractionated or...

Read More

Evaluating the effects on survival of chemotherapy after surgery to remove liver or lung metastases in patients with colorectal cancer

Evaluating the effects on survival of chemotherapy after surgery to remove liver or lung metastases in patients with colorectal cancer

Posted by on Jul 20, 2013 in Colorectal cancer | 0 comments

In a nutshell This article evaluated the effects of chemotherapy after the surgical removal of liver and lung metastases on survival in patients with colorectal cancer (CRC).  Some background Metastatic CRC is cancer that has spread from the large intestine to distant organs or tissues in the body. The parts of the body mainly affected by...

Read More